Haemonetics Corporation HAE
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Haemonetics Corporation is a global healthcare company dedicated to providing innovative blood management solutions for organizations around the world. The company plays a crucial role in the healthcare industry by offering devices and services that aim to improve the quality, efficiency, and safety of blood supply. Ha…
SectorHealthcare
ExchangeNYSE
IndustryMedical Devices
CountryUnited States
Employees3,657
TickerHAE
Statistics
Market Cap$3.31B
Revenue (TTM)$1.33B
Net Income$97.3M
Net Margin7.3%
EPS$2.05
P/E34.67
P/S2.55
P/B4.26
EV/EBITDA12.41
ROE12.0%
Dividend Yield—
Price$73.04
Data: Twelve Data · Revenue = mcap / P/S